• Most Popular
  • Most Shared

Lawmakers question Vytorin cancer risk data

WASHINGTON
Thu Aug 21, 2008 12:26pm EDT

WASHINGTON (Reuters) - Two top Democratic lawmakers on Thursday questioned recent claims by Merck & Co Inc and Schering Plough Corp that incidents of cancer in patients taking their cholesterol drug Vytorin were a fluke.

U.S.  |  Barack Obama  |  Health  |  Stocks  |  Regulatory News

The lawmakers, Rep. John Dingell and Rep. Bart Stupak, both from Michigan, are seeking 10 years of related company records after a study last month found Vytorin patients had a higher rate of cancer than those taking a placebo.

(Reporting by Susan Heavey; editing by John Wallace)
U.S.
Barack Obama
Health
Stocks
Regulatory News


More from Reuters

Photo

Pay czar caps more salaries at bailed out firms

WASHINGTON/NEW YORK (Reuters) - The U.S. pay czar on Friday expanded a crackdown on pay packages at four companies rescued with taxpayer money, limiting most cash salaries at $500,000 for a second tier of top earners.

» More Top News
A model gets prepared backstage ahead of a wedding dress show at China Fashion Week in Beijing
Fashion & Style:

Flowers, church, liposuction?

Brides and grooms are opting for cosmetic surgery and other procedures, supplementing veils and cummerbunds with Botox and liposuction. Women say they want to look good for photos, but men are a different story.  Full Article 

Lifestyle
Sam Worthington and Zoe Saldana as her digital character Neytiri in a scene from "Avatar". Credit: REUTERS/Twentieth Century Fox/Handout

Will Cameron change Hollywood again?

Beyond the hype and buzz, James Cameron's $400 million "Avatar," one of the most expensive films ever made, is being closely watched for its impact on the future of movies.  Full Article 

Entertainment